VIR FY 2021 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.1B+1529.0% YoY

Gross Profit

$582M53.1% margin

Operating Income

$421M38.4% margin

Net Income

$529M48.3% margin

EPS (Diluted)

$3.96

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$69M

Stock-Based Comp.

$84M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$522M

Stockholders' Equity

$1.4B

Cash & Equivalents

$348M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$67M	+1529.0%
Gross Profit	$582M	$67M	+764.8%
Operating Income	$421M	-$297M	+241.7%
Net Income	$529M	-$299M	+277.0%